- Home
- VCYT vs PENN Comparison
VCYT vs PENN Comparison
Compare VCYT & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCYT | PENN |
|---|---|---|
| Founded | 2006 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2013 | 1996 |
Fundamental Metrics
Financial Performance| Metric | VCYT | PENN |
|---|---|---|
| Price | $55.59 | $20.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $44.00 | $20.83 |
| AVG Volume (30 Days) | 1.4M | ★ 3.9M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | N/A | ★ $6,362,900,000.00 |
| Revenue This Year | $13.76 | $6.85 |
| Revenue Next Year | $12.35 | $3.83 |
| P/E Ratio | $165.70 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.61 | $11.65 |
| 52 Week High | $60.91 | $22.36 |
Technical Indicators
Market Signals| Indicator | VCYT | PENN |
|---|---|---|
| Relative Strength Index (RSI) | 58.01 | 52.55 |
| Support Level | $40.27 | $19.94 |
| Resistance Level | N/A | $22.35 |
| Average True Range (ATR) | 2.80 | 0.81 |
| MACD | -0.26 | -0.18 |
| Stochastic Oscillator | 53.44 | 34.09 |
Price Performance
Historical ComparisonAbout VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 42 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 81% of total sales in 2025; 19% was from the interactive segment, which includes sports, i-gaming, and media revenue. The retail portfolio generates low-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media asset, theScore, provides access to sports betting/i-gaming technology and clientele, helping it form a leading digital position.